Our initial series, Pathways: ASBMR Stories of Discovery, is hosted by Dr. Michael Econs, Distinguished Professor at the Indiana University School of Medicine. Throughout this three part series, we speak with pioneers in discovery of FGF23. We explore dysregulation of FGF23 in renal failure, inhibiting FGF23 for treatment of XLH, and the interplay of FGF23 and iron.
Episode one features a X-linked Hypophosphatemia-focused discussion with Dr. Thomas Carpenter. Dr. Carpenter has maintained a career-long involvement in metabolic bone diseases in children. He currently serves as director of the Yale Center for X-linked Hypophosphatemia (XLH) and as the Medical Director of the Yale Center for Clinical Investigation's Hospital Research Unit. His research interests center on the pathophysiology and development of therapy for XLH, the most common inherited form of rickets. He also has a major interest in the metabolism and function of vitamin D, and disorders related to vitamin D in children. He has published over 200 articles, reviews and chapters with a focus of metabolic bone diseases in children, and is currently an Associate Editor of the Journal of Bone and Mineral Research.
Be sure to subscribe to tune in for future episodes. Thank you for joining us!
Our initial series, Pathways: ASBMR Stories of Discovery, is hosted by Dr. Michael Econs, Distinguished Professor at the Indiana University School of Medicine. Throughout this three part series, we speak with pioneers in discovery of FGF23. We explore dysregulation of FGF23 in renal failure, inhibiting FGF23 for treatment of XLH, and the interplay of FGF23 and iron.
Episode one features a X-linked Hypophosphatemia-focused discussion with Dr. Thomas Carpenter. Dr. Carpenter has maintained a career-long involvement in metabolic bone diseases in children. He currently serves as director of the Yale Center for X-linked Hypophosphatemia (XLH) and as the Medical Director of the Yale Center for Clinical Investigation's Hospital Research Unit. His research interests center on the pathophysiology and development of therapy for XLH, the most common inherited form of rickets. He also has a major interest in the metabolism and function of vitamin D, and disorders related to vitamin D in children. He has published over 200 articles, reviews and chapters with a focus of metabolic bone diseases in children, and is currently an Associate Editor of the Journal of Bone and Mineral Research.
Be sure to subscribe to tune in for future episodes. Thank you for joining us!